RAD001 and zoledronic acid in renal cell carcinoma patients with bone metastases (RAZOR): A randomized phase II trial.
Reuben James Broom
Consultant or Advisory Role - Novartis (U)
Honoraria - Novartis
Vicky Hinder
No relevant relationships to disclose
Katrina Sharples
No relevant relationships to disclose
Janie Proctor
No relevant relationships to disclose
Steven Duffey
No relevant relationships to disclose
Stephanie Pollard
No relevant relationships to disclose
Peter C.C. Fong
No relevant relationships to disclose
Garry Forgeson
No relevant relationships to disclose
Dean Laurence Harris
No relevant relationships to disclose
Michael B. Jameson
No relevant relationships to disclose
Anne O'Donnell
No relevant relationships to disclose
Richard T. North
No relevant relationships to disclose
Sanjeev Deva
No relevant relationships to disclose
Fritha J. Hanning
No relevant relationships to disclose
Andrew Grey
No relevant relationships to disclose
Michael P. N. Findlay
No relevant relationships to disclose